Condition

Salt; Excess

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 11 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials11

Recruiting2

Common interventions17

Lead sponsors shown8

Clinical trials

11 shown

Ketone Ester And Salt (KEAS) in Older AdultsNCT06868719 · 2025-03-06

RECRUITING

Ketone Ester and Salt (KEAS) in Young AdultsNCT05545501 · 2023-03-24

RECRUITING

Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 DiabetesNCT06007157 · 2023-03-01

UNKNOWN

Intervention for Monitoring of Salt Intake in Hypertensive PatientsNCT05397054 · 2022-01-10

UNKNOWN

Salt-Sensitivity and Immunity Cell ActivationNCT03753204 · 2021-09-01

ACTIVE_NOT_RECRUITING

Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.NCT04556279 · 2021-01-01

WITHDRAWN

Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African AmericansNCT04021355 · 2020-11-14

COMPLETED

Genetic of Response to Acute Saline Load Test in Hypertension (Naload)NCT04625569 · 2019-07-08

UNKNOWN

Study With an Innovative Equipment to Monitor and Control SALT During CookingNCT03974477 · 2019-06-01

UNKNOWN

Visualizing Vascular Mechanisms of Salt SensitivityNCT03696433 · 2019-02-01

COMPLETED

Impact of Self-monitoring of Salt Intake by Salt Meter in Hypertensive PatientsNCT04286802 · 2017-07-11

UNKNOWN

Common interventions

EducationBEHAVIORAL2 High Salt, High β-OHBDIETARY_SUPPLEMENT2 High Salt, No β-OHBDIETARY_SUPPLEMENT2 No Salt, No β-OHBDIETARY_SUPPLEMENT2 adrenalectomyPROCEDURE1 Aldosterone AntagonistDRUG1 Environmental changeBEHAVIORAL1 Furosemide 40 mgDRUG1 High-salt dietDIETARY_SUPPLEMENT1 Hypersodic/Hyposodic dietBEHAVIORAL1 Low-salt dietDIETARY_SUPPLEMENT1 Oral sodium supplementationOTHER1 ReformulationBEHAVIORAL1 SALT CONTROL H equipment to control and monitor salt during cooking processDEVICE1 Salt meterDEVICE1 Salt-meterDEVICE1 standard treatmentBEHAVIORAL1

Leading sponsors

Indiana University2 Mahidol University2 Vanderbilt University Medical Center2 Azienda Ospedaliero, Universitaria Pisana1 Imperial College London1 Ospedale San Raffaele1 Universidade do Porto1 University of Alabama at Birmingham1

Trial status mix

UNKNOWN5

COMPLETED2

RECRUITING2

ACTIVE_NOT_RECRUITING1

WITHDRAWN1

Phase mix

NA8

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.